DELALUTIN Trademark

Trademark Overview

On Thursday, August 16, 2018, a trademark application was filed for DELALUTIN with the United States Patent and Trademark Office. The USPTO has given the DELALUTIN trademark a serial number of 88081202. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 4, 2022. This trademark is owned by Aspen Global Incorporated. The DELALUTIN trademark is filed in the Pharmaceutical Products category with the following description:

Progesterone preparation
delalutin

General Information

Serial Number88081202
Word MarkDELALUTIN
Filing DateThursday, August 16, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 1, 2019

Trademark Statements

Goods and ServicesProgesterone preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 25, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAspen Global Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Bay BRNCO8078
MU
Party NameAspen Global Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Bay
MU

Trademark Events

Event DateEvent Description
Monday, April 4, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 21, 2021EXTENSION 5 GRANTED
Wednesday, July 14, 2021EXTENSION 5 FILED
Wednesday, July 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 14, 2021TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 22, 2021EXTENSION 4 GRANTED
Friday, January 22, 2021EXTENSION 4 FILED
Friday, January 22, 2021TEAS EXTENSION RECEIVED
Wednesday, July 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 27, 2020EXTENSION 3 GRANTED
Monday, July 27, 2020EXTENSION 3 FILED
Monday, July 27, 2020TEAS EXTENSION RECEIVED
Thursday, January 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 28, 2020EXTENSION 2 GRANTED
Tuesday, January 28, 2020EXTENSION 2 FILED
Tuesday, January 28, 2020TEAS EXTENSION RECEIVED
Friday, August 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2019EXTENSION 1 GRANTED
Wednesday, July 31, 2019EXTENSION 1 FILED
Wednesday, July 31, 2019TEAS EXTENSION RECEIVED
Tuesday, February 26, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 1, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 1, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 28, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 28, 2018ASSIGNED TO EXAMINER
Saturday, August 25, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 20, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

delalutin preparation progesterone